AU2001258575A1 - Treatment of cancer and neurological diseases - Google Patents
Treatment of cancer and neurological diseasesInfo
- Publication number
- AU2001258575A1 AU2001258575A1 AU2001258575A AU5857501A AU2001258575A1 AU 2001258575 A1 AU2001258575 A1 AU 2001258575A1 AU 2001258575 A AU2001258575 A AU 2001258575A AU 5857501 A AU5857501 A AU 5857501A AU 2001258575 A1 AU2001258575 A1 AU 2001258575A1
- Authority
- AU
- Australia
- Prior art keywords
- cancer
- treatment
- neurological diseases
- neurological
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0012186.3A GB0012186D0 (en) | 2000-05-20 | 2000-05-20 | Treatment of cancer and neurological diseases |
GB0012186 | 2000-05-20 | ||
PCT/GB2001/002240 WO2001090354A1 (en) | 2000-05-20 | 2001-05-21 | Treatment of cancer and neurological diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001258575A1 true AU2001258575A1 (en) | 2001-12-03 |
Family
ID=9891971
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001258575A Abandoned AU2001258575A1 (en) | 2000-05-20 | 2001-05-21 | Treatment of cancer and neurological diseases |
Country Status (5)
Country | Link |
---|---|
US (1) | US20030180750A1 (en) |
EP (1) | EP1283883A1 (en) |
AU (1) | AU2001258575A1 (en) |
GB (1) | GB0012186D0 (en) |
WO (1) | WO2001090354A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1820861A3 (en) * | 2000-08-02 | 2007-08-29 | Amgen Inc. | C3B/C4B complement receptor-like molecules and uses thereof |
AU2001280733B2 (en) * | 2000-08-02 | 2007-04-26 | Amgen Inc. | C3B/C4B complement receptor-like molecules and uses thereof |
US7608704B2 (en) | 2000-11-08 | 2009-10-27 | Incyte Corporation | Secreted proteins |
EP1341812A2 (en) * | 2000-11-08 | 2003-09-10 | Incyte Genomics, Inc. | Secreted proteins |
WO2002064791A2 (en) * | 2000-12-08 | 2002-08-22 | Curagen Corporation | Proteins and nucleic acids encoding same |
US6975943B2 (en) | 2001-09-24 | 2005-12-13 | Seqwright, Inc. | Clone-array pooled shotgun strategy for nucleic acid sequencing |
-
2000
- 2000-05-20 GB GBGB0012186.3A patent/GB0012186D0/en not_active Ceased
-
2001
- 2001-05-21 US US10/276,934 patent/US20030180750A1/en not_active Abandoned
- 2001-05-21 WO PCT/GB2001/002240 patent/WO2001090354A1/en not_active Application Discontinuation
- 2001-05-21 EP EP01931884A patent/EP1283883A1/en not_active Withdrawn
- 2001-05-21 AU AU2001258575A patent/AU2001258575A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20030180750A1 (en) | 2003-09-25 |
GB0012186D0 (en) | 2000-07-12 |
WO2001090354A1 (en) | 2001-11-29 |
EP1283883A1 (en) | 2003-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002332430A1 (en) | Methods of treating neuropilin-mediated diseases | |
AU2002239491A1 (en) | Methods for the treatment of cancer and other diseases and methods of developing the same | |
AU2002324914A1 (en) | Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith | |
AU2001279707A1 (en) | Diagnosis of behavioural disorders, neurological disorders and cancer | |
AU7434101A (en) | Treatment of bone diseases | |
AU7863201A (en) | Treatment of hyperproliferative diseases | |
AUPQ923100A0 (en) | Treatment of prostate cancer | |
AUPQ877300A0 (en) | Topical treatment of skin | |
AU2000258352A1 (en) | Acupuncture points stimulation for treating various diseases | |
AU2002237667A1 (en) | Methods for the treatment and prevention of urinary stone disease | |
AUPQ201499A0 (en) | Treatment of inflammatory and malignant diseases | |
AU2001259085A1 (en) | Treatment of ocular neovascularization and related diseases | |
AU3896900A (en) | Treatment of pain | |
AUPQ344799A0 (en) | Treatment of respiratory diseases and infections | |
AU2001258575A1 (en) | Treatment of cancer and neurological diseases | |
AU7106300A (en) | Treatment of skin disorders | |
AU2002229986A1 (en) | Method of treating neurological diseases | |
AU7636800A (en) | Improved ricin-like toxins for treatment of cancer | |
AU4215499A (en) | Treatment of neurodegenerative diseases | |
AU2001245414A1 (en) | Treatment of allergies | |
AUPQ367699A0 (en) | Treatment of cancer | |
AU5552400A (en) | Treatment of cancer | |
AU2003213898A1 (en) | Prevention and treatment of mycoplasma-associated diseases | |
AU2001267165A1 (en) | Prevention and treatment of mycoplasma-associated diseases | |
AU1405001A (en) | Treatment of diseases |